Pluri Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Pluri Inc. (PLUR) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$2.00 million for the 12-month period ending 2018-06-30, per its 10-K filed 2020-09-10.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2020-09-10
- Pluri Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- Pluri Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2018-03-31 was -$5.38M, a 652.16% decline year-over-year.
- Pluri Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2017-12-31 was $4.43M.
- Pluri Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2017-09-30 was -$1.05M, a 281.27% decline year-over-year.
- Pluri Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2018 was -$2.00M, a 485.16% decline from fiscal 2017.
- Pluri Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2017 was $519.00K.
- Pluri Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2016 was -$660.00K.
- Pluri Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2015 was -$819.00K, a 130.33% decline from fiscal 2014.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2018-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-10 | -$5.38M derived: sum of 2 quarters · filed 2020-09-10 | -$944.00K derived: sum of 3 quarters · filed 2020-09-10 | -$2.00M 10-K · filed 2020-09-10 |
| 2018-03-31 | -$5.38M 10-Q · filed 2019-05-06 | -$944.00K derived: sum of 2 quarters · filed 2019-05-06 | -$2.00M 10-Q · filed 2019-05-06 | -$1.44M derived: sum of 4 quarters · filed 2019-09-12 |
| 2017-12-31 | $4.43M 10-Q · filed 2019-02-06 | $3.38M 10-Q · filed 2019-02-06 | $3.94M derived: sum of 3 quarters · filed 2019-09-12 | $4.92M derived: sum of 4 quarters · filed 2019-09-12 |
| 2017-09-30 | -$1.05M 10-Q · filed 2018-11-07 | -$491.00K derived: sum of 2 quarters · filed 2019-09-12 | $483.00K derived: sum of 3 quarters · filed 2019-09-12 | -$1.12M derived: sum of 4 quarters · filed 2019-09-12 |
| 2017-06-30 | $564.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-12 | $1.54M derived: sum of 2 quarters · filed 2019-09-12 | -$63.00K derived: sum of 3 quarters · filed 2019-09-12 | $519.00K 10-K · filed 2019-09-12 |
| 2017-03-31 | $974.00K 10-Q · filed 2018-05-09 | -$627.00K derived: sum of 2 quarters · filed 2018-05-09 | -$45.00K 10-Q · filed 2018-05-09 | $504.00K derived: sum of 4 quarters · filed 2018-09-12 |
| 2016-12-31 | -$1.60M 10-Q · filed 2018-02-06 | -$1.02M 10-Q · filed 2018-02-06 | -$470.00K derived: sum of 3 quarters · filed 2018-09-12 | -$307.00K derived: sum of 4 quarters · filed 2018-09-12 |
| 2016-09-30 | $582.00K 10-Q · filed 2017-11-07 | $1.13M derived: sum of 2 quarters · filed 2018-09-12 | $1.29M derived: sum of 3 quarters · filed 2018-09-12 | $1.62M derived: sum of 4 quarters · filed 2018-09-12 |
| 2016-06-30 | $549.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-12 | $712.00K derived: sum of 2 quarters · filed 2018-09-12 | $1.04M derived: sum of 3 quarters · filed 2018-09-12 | -$660.00K 10-K · filed 2018-09-12 |
| 2016-03-31 | $163.00K 10-Q · filed 2017-05-08 | $489.00K derived: sum of 2 quarters · filed 2017-05-08 | -$1.21M 10-Q · filed 2017-05-08 | -$565.00K derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-12-31 | $326.00K 10-Q · filed 2017-02-08 | -$1.37M 10-Q · filed 2017-02-08 | -$728.00K derived: sum of 3 quarters · filed 2017-09-07 | $1.17M derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-09-30 | -$1.70M 10-Q · filed 2016-11-07 | -$1.05M derived: sum of 2 quarters · filed 2017-09-07 | $841.00K derived: sum of 3 quarters · filed 2017-09-07 | $1.17M derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-06-30 | $644.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | $2.54M derived: sum of 2 quarters · filed 2017-09-07 | $2.87M derived: sum of 3 quarters · filed 2017-09-07 | -$819.00K 10-K · filed 2017-09-07 |
| 2015-03-31 | $1.90M 10-Q · filed 2016-05-09 | $2.23M derived: sum of 2 quarters · filed 2016-05-09 | -$1.46M 10-Q · filed 2016-05-09 | -$1.38M derived: sum of 4 quarters · filed 2016-09-07 |
| 2014-12-31 | $330.00K 10-Q · filed 2016-02-08 | -$3.36M 10-Q · filed 2016-02-08 | -$3.27M derived: sum of 3 quarters · filed 2016-09-07 | -$1.56M derived: sum of 4 quarters · filed 2016-09-07 |
| 2014-09-30 | -$3.69M 10-Q · filed 2015-11-05 | -$3.60M derived: sum of 2 quarters · filed 2016-09-07 | -$1.89M derived: sum of 3 quarters · filed 2016-09-07 | -$1.38M derived: sum of 4 quarters · filed 2016-09-07 |
| 2014-06-30 | $84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-07 | $1.80M derived: sum of 2 quarters · filed 2016-09-07 | $2.30M derived: sum of 3 quarters · filed 2016-09-07 | $2.70M 10-K · filed 2016-09-07 |
| 2014-03-31 | $1.72M 10-Q · filed 2015-05-06 | $2.22M derived: sum of 2 quarters · filed 2015-05-06 | $2.62M 10-Q · filed 2015-05-06 | |
| 2013-12-31 | $504.00K 10-Q · filed 2015-02-05 | $899.00K 10-Q · filed 2015-02-05 | ||
| 2013-09-30 | $395.00K 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |